FMP

FMP

Enter

BCTX - BriaCell Therapeutics Corp.

Profile of BriaCell Therapeutics Corp.(BCTX), BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunot

About

ceo

Dr. William V. Williams M.D.

sector

Healthcare

industry

Biotechnology

website

https://www.briacell.com

exchange

NASDAQ

Description

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

CIK

0001610820

ISIN

CA1079301091

CUSIP

10778Y302

Address

Bellevue Centre

Phone

604 921 1810

Country

CA

Employee

16

IPO Date

Mar 14, 2012

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep